Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Debridement & negative-pressure wound therapy · Florida | Debridement & negative-pressure wound therapy · Texas | |
|---|---|---|
| Surgeons, 2024 | 1,336 | 1,025 |
| Medicare fee-for-service cases | 505,568 | 283,370 |
| Growth since 2019 (Medicare FFS) | +2.5%/yr | +3.6%/yr |
| Forecast cases (Medicare FFS) | 587,700 in 2030 | 394,700 in 2030 |
| Forecast growth | +2.5%/yr to 2030 | +5.7%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 215.0 | 125.0 |
| Medicare Advantage share | 60% | 59% |
| Out of hospital | 54% (+1 pts since 2019) | 51% (+13 pts since 2019) |
| Cases per surgeon | 378 | 276 |
| Top 10 surgeons' share | 13% | 16% |
| Surgeons growing | 263 | 174 |
| New since the base year | 460 | 409 |
| Likely to stop billing it | 210 by 2026 | 181 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $1,233 | $1,556 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.